Work-Related Condition — Congitive Behavioral Therapy Workshop for Content Moderators
Citation(s)
Léonard, M -J., Saumier, D., & Brunet, A. (2020). When the lawyer becomes traumatized: A scoping review. SAGE Open, 10(3), 1-10. https://doi.org/10.1177/2158244020957032
Lewis C, Roberts NP, Andrew M, Starling E, Bisson JI Psychological therapies for post-traumatic stress disorder in adults: systematic review and meta-analysis. Eur J Psychotraumatol. 2020 Mar 10;11(1):1729633. doi: 10.1080/20008198.2020.1729633. eCollection 2020.
Seigfried-Spellar, K C. (2018) Assessing the Psychological Well-being and Coping Mechanisms of Law Enforcement Investigators vs. Digital Forensic Examiners of Child Pornography Investigations. Journal of Police and Criminal Psychology, 33, 215-226. https://doi.org/10.1007/s11896-017-9248-7
Spence, R , Bifulco, A., Bradbury, P., Martellozzo, E., & DeMarco, J. (2023a). The psychological impacts of content moderation on content moderators: A qualitative study. Cyberpsychology: Journal of Psychosocial Research on Cyberspace, 17(4), Article X. https://doi.org/10.5817/CP2023-X-X
Steiger, M , Bharucha, T. J., Venkatagiri, S., Riedl, M. J., & Lease, M. (2021). The psychological well-being of content moderators: The emotional labor of commercial moderation and avenues for improving support. In CHI '21: Proceedings of the 2021 CHI Conference on Human Factors in Computing Systems (pp. 1-14). ACM. https://doi.org/10.1145/3411764.3445092
Acceptability and Feasibility of a Congitive Behavioral Therapy Workshop for Content Moderators: A Pilot Study
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
